Cargando…
Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results
BACKGROUND: Careful selection of hepatocellular carcinoma (HCC) patients prior to chemoembolization treatment is a daily reality, and is even more necessary with new available therapeutic options in HCC. AIM: To propose two new models to better stratify patients and maximize clinical benefit: “6 and...
Autores principales: | Adhoute, Xavier, Larrey, Edouard, Anty, Rodolphe, Chevallier, Patrick, Penaranda, Guillaume, Tran, Albert, Bronowicki, Jean-Pierre, Raoul, Jean-Luc, Castellani, Paul, Perrier, Hervé, Bayle, Olivier, Monnet, Olivier, Pol, Bernard, Bourliere, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223847/ https://www.ncbi.nlm.nih.gov/pubmed/34222423 http://dx.doi.org/10.12998/wjcc.v9.i18.4559 |
Ejemplares similares
-
“Six-and-twelve” score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohort
por: Adhoute, Xavier, et al.
Publicado: (2020) -
Transarterial chemoembolization (TACE) plus sorafenib: a real winning combination?
por: Adhoute, Xavier, et al.
Publicado: (2020) -
Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort
por: Adhoute, Xavier, et al.
Publicado: (2017) -
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
por: Adhoute, Xavier, et al.
Publicado: (2022) -
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis
por: Adhoute, Xavier, et al.
Publicado: (2023)